about
Coenzyme Q10 and congestive heart failure; an evolving evidence basePlasma lipids and betaine are related in an acute coronary syndrome cohortThe contrasting relationships between betaine and homocysteine in two clinical cohorts are associated with plasma lipids and drug treatmentsEffect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.Betaine and secondary events in an acute coronary syndrome cohort.Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational StudyCoenzyme Q10: is there a clinical role and a case for measurement?Biological variation of coenzyme Q10.Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure.A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome.Coenzyme Q10: an independent predictor of mortality in chronic heart failure.An investigation of the antioxidant properties and colour of glasshouse grown tomatoes.Compound Heterozygous Inheritance of Mutations in Coenzyme Q8A Results in Autosomal Recessive Cerebellar Ataxia and Coenzyme Q10 Deficiency in a Female Sib-Pair.Pharmacokinetic comparison of a generic coenzyme Q₁₀ solubilizate and a formulation with soybean phytosterols.Rosuvastatin in Older Patients with Systolic Heart FailurePlasma total coenzyme Q9 (CoQ9) in the New Zealand population: reference interval and biological variationThe bioavailability of coenzyme Q10 supplements available in New Zealand differs markedlyFluorescence is less sensitive than ultraviolet or electrochemical detection for measurement of coenzyme Q10 in plasmaRelationship between plasma coenzyme Q10, asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long-term statin therapyCoenzyme Q10; an adjunctive therapy for congestive heart failure?Inorganic arsenic in rice and rice products in New Zealand and AustraliaN-3 polyunsaturated fatty acids and statins in heart failure
P50
Q28080918-5A79C5C5-465E-476A-B69F-028BB134F509Q28478910-33F5A069-9EDA-4467-9EEC-C4B0167F3B28Q28481369-CB16075C-3645-482E-A81E-D3486B3373F7Q34007689-F340F9DB-2716-42BD-88A7-959000B6B512Q34287613-D5CED138-C2AA-4D43-8ED6-0DA321153ABDQ34672965-7297D75A-FFBF-4211-8E25-69154C7417F7Q36869671-9E292CDC-1F6F-40BF-AB7A-A2E36CDCF470Q45244891-9E540186-2C7F-42E5-AD8E-7169FA5294A7Q45273994-E574C60A-9525-4CF4-92FC-D1B15801803CQ45794848-4F67B5C5-7D2D-4899-89C6-420543AAC2C4Q46239711-37DB3A83-5A71-4CA9-8BF7-D2BA0E3D45A8Q46600379-9941E016-0F2E-4FA0-A8CB-95D1EE46C3C8Q47380247-F02C1805-95F8-4D51-800B-1A5663F886FBQ51362811-56BD4920-28C4-471D-96A5-060087F0B160Q57396292-C7AD2EE0-251B-4D8D-917B-0172FF3C26D5Q80092240-3D1CAF67-DE74-4E71-A911-2C490601EF99Q80847964-5E6F7E5C-2B6F-4A9E-B880-1A74701CD062Q81844779-CDBB6CE5-4C42-49A6-AF1B-5BFE3A889E3FQ84271859-26CC8558-C8B0-468C-A53D-3713AB46A2A5Q84992866-47E3F2F0-FC04-4609-B9BA-F11FA374E162Q92598695-65F54AEA-D2EF-41BC-8DF1-1DDFC29C72B3Q94847470-9C37FE57-69F2-4A98-997B-6A908FC978CD
P50
description
researcher ORCID ID = 0000-0001-6816-5619
@en
wetenschapper
@nl
name
Sarah Molyneux
@ast
Sarah Molyneux
@en
Sarah Molyneux
@es
Sarah Molyneux
@nl
type
label
Sarah Molyneux
@ast
Sarah Molyneux
@en
Sarah Molyneux
@es
Sarah Molyneux
@nl
prefLabel
Sarah Molyneux
@ast
Sarah Molyneux
@en
Sarah Molyneux
@es
Sarah Molyneux
@nl
P106
P21
P31
P496
0000-0001-6816-5619